Mild to Moderate Crohn's Disease in Children: High Dose Oral 4-Aminosalicylic Acid (PASER) to Control Acute Flares
California, Georgia, New Jersey, Texas. clinicaltrials.gov
This story published in Digestive Health SmartBrief on 09/03/2008
More from SmartBrief:
Study Registry to Evaluate the Long-Term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Wednesday, September 16, 2009
Barrett's Esophagus & Gastroesophageal Reflux Disease
Wednesday, October 14, 2009
Older Colon Cancer Patients: Study of Economic Circumstances, Service Utilization, and Service Needs
Wednesday, November 11, 2009
Get stories like these delivered daily for FREE:
|
Digestive Health SmartBrief
From the American College of Gastroenterology and its member physicians, Digestive Health SmartBrief is a free, twice-weekly newsletter. It provides news and information for your digestive health, including stories on healthy living, developments in diagnosis and treatment, and important legislation shaping the health care landscape. You'll also find a clinical trial monitor, patient perspectives, and a resource center. Come sign up today. Learn more |
|